Table 1 The baseline characteristics of patients in the entire study population
Parameters | Overall (n = 120) | With CBCT (n = 69) | Without CBCT (n = 51) | P |
|---|---|---|---|---|
Age (years) | 49.4 ± 10.3 | 49.4 ± 11.2 | 49.9 ± 9.0 | 0.690# |
Gender (%) | 0.147* | |||
Male | 61 (50.8%) | 39 (56.5%) | 22 (43.1%) | |
Female | 59 (49.2%) | 30 (43.5%) | 29 (56.9%) | |
Body mass index (kg/m2) | 24.8 (IQR: 4.1) | 25.8 ± 4.2 | 24.5 ± 2.7 | 0.062# |
Lowest kalemia (mmol/l) | 3.3 (IQR: 0.8) | 3.4 (IQR: 0.8) | 3.3 ± 0.5 | 0.273^ |
Systolic blood pressure (mm Hg) | 157.1 ± 21.6 | 158.8 ± 21.2 | 154.8 ± 22.1 | 0.316# |
Diastolic blood pressure (mm Hg) | 96.1 ± 14.8 | 95.7 ± 14.9 | 96.6 ± 14.8 | 0.749# |
Plasma supine Aldosterone (ng/dl) | 28.8 (IQR: 36.9) | 29.7 (IQR: 23.2) | 24.6 (IQR: 44.8) | 0.574^ |
Plasma upright Aldosterone (ng/dl) | 31.9 (IQR: 31.6) | 32.3 (IQR: 29.1) | 28.8 (IQR: 37.9) | 0.804^ |
Plasma supine active renin (ng/ml.h) | 0.5 (IQR: 1.1) | 0.6 (IQR: 1.0) | 0.5 (IQR: 1.3) | 0.902^ |
Plasma upright active renin (ng/ml.h) | 0.8 (IQR: 1.8) | 0.8 (IQR: 1.7) | 0.9 (IQR: 2.0) | 0.706^ |
Aldosterone-to-renin ratio | 44.7 (IQR: 97.6) | 44.7 (IQR: 72.2) | 52.2 (IQR: 125.1) | 0.512^ |
Success rate (%) | 85.8% | 88.4% | 82.3% | 0.347* |
Radiation dose (mGy) | 617.0 (IQR: 784.2) | 694.0 (IQR: 940.5) | 490.0 (IQR: 718.0) | 0.018^ |
Sampling time (min) | 93 (IQR: 40.0) | 101 (IQR: 44) | 87.3 ± 32.0 | 0.001^ |